Afton Hassett, PhD, delved into the relationship between the psychological impact of rheumatic diseases and their effects on individuals’ physical symptoms and overall well-being. She also discussed effective intervention strategies.
Jamie E. Collins, PhD, defined the types of artificial intelligence rheumatologists might encounter, as well as the potential benefits and risks of this quickly developing technology in healthcare applications.
Being born female increases risk of autoimmune disease four-fold compared to males. Montserrat C. Anguera, PhD, opened a session on research indicating flaws in the mechanism that protects females from overexposure to their own X chromosomes are the cause.
Prescribing a medication to stimulate weight loss is a convenient option for patients, but clinicians must also account for factors such as cost and the long-term welfare of their patients. Stephen Messier, PhD, and Martin Englund, MD, PhD, weighed the merits of these therapeutic philosophies.
Incomplete renal response, prolonged time to renal response, renal flares, steroid toxicity, tolerability and adherence, and the lack of data in the pediatric population complicate the management of young patients with severe lupus nephritis, said Stacy Ardoin, MD.
Experts including Troy Torgerson, MD, PhD, shared insights for optimal genetic testing strategies in the era of inborn errors of immunity, as well as challenges they hope to overcome in the future.